Global Automated Cell Culture Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Type;

Modular Automation and Whole Lab Automation.

By Product;

Consumables and Vessels.

By Application;

Biopharmaceutical Production, Tissue Engineering & Regenerative Medicine , Drug Screening& Development , Gene Therapy , Stem Cell Research , Diagnostics and Toxicity Testing.

By End User;

Pharmaceutical & Biotechnology Companies , Research Institutes, Hospitals & Diagnostic Laboratories and Cell Banks.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn132519024 Published Date: October, 2024 Updated Date: November, 2024

Introduction

Global Automated Cell Culture Market (USD Million), 2020 - 2030

In the year 2023, the Global Automated Cell Culture Market was valued at USD 17,840.64 million. The size of this market is expected to increase to USD 31,377.28 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.

The global automated cell culture market is experiencing robust growth driven by advancements in biotechnology, pharmaceuticals, and regenerative medicine. Automated cell culture systems represent a significant evolution in biomedical research and industrial bioprocessing, offering enhanced efficiency, reproducibility, and scalability compared to traditional methods. These systems automate various tasks involved in cell culture, such as media exchange, feeding, monitoring, and analysis, thereby reducing labor-intensive manual interventions and minimizing contamination risks.

One of the key drivers propelling market expansion is the increasing demand for efficient production of biologics, including vaccines, monoclonal antibodies, and cell-based therapies. These products require precise control over cell culture conditions to ensure consistent quality and yield, which automated systems can achieve through real-time monitoring and feedback mechanisms.

The rise of personalized medicine and the growing adoption of cell-based assays in drug discovery and toxicity testing are further boosting the demand for automated cell culture solutions. These systems enable researchers to perform high-throughput screening and optimize conditions for culturing diverse cell types, supporting the development of novel therapies and diagnostics.

Technological advancements such as integration with artificial intelligence (AI) and machine learning are also revolutionizing automated cell culture. AI algorithms can analyze large datasets generated during cell culture processes to optimize conditions, predict outcomes, and accelerate research timelines. Furthermore, miniaturization and microfluidic technologies are enhancing the scalability and throughput of automated systems, making them increasingly attractive for both research laboratories and industrial biomanufacturing facilities.

Geographically, North America and Europe currently dominate the automated cell culture market due to strong investments in biomedical research, well-established healthcare infrastructure, and a high concentration of biopharmaceutical companies. However, rapid economic development and increasing healthcare expenditure in Asia-Pacific countries are expected to drive significant market growth in the coming years.

In conclusion, the global automated cell culture market is poised for substantial expansion driven by technological innovation, increasing applications in biopharmaceuticals and regenerative medicine, and growing investments in healthcare infrastructure worldwide. As automation continues to redefine cell culture practices, stakeholders across the biomedical and pharmaceutical sectors are poised to benefit from improved efficiency, reduced costs, and accelerated development of advanced therapies and treatments.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Product
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Automated Cell Culture Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Precision and reproducibility

        2. Increased demand for biologics

        3. Growing prevalence of chronic diseases

        4. Need for high-throughput screening

      2. Restraints
        1. High initial costs

        2. Limited skilled workforce

        3. Concerns over data security

        4. Compatibility issues with existing systems

      3. Opportunities
        1. Development of personalized medicine

        2. Integration of AI and machine learning

        3. Expansion in pharmaceutical Industries

        4. Rising investments in R&D

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Automated Cell Culture Market, By Type, 2020 - 2030 (USD Million)
      1. Modular Automation
      2. Whole Lab Automation
    2. Global Automated Cell Culture Market, By Product, 2020 - 2030 (USD Million)
      1. Consumables
      2. Vessels
    3. Global Automated Cell Culture Market, By Application, 2020 - 2030 (USD Million)
      1. Biopharmaceutical Production
      2. Tissue Engineering & Regenerative Medicine
      3. Drug Screening & Development
      4. Gene Therapy
      5. Stem Cell Research
      6. Diagnostics
      7. Toxicity Testing
    4. Global Automated Cell Culture Market, By End User, 2020 - 2030 (USD Million)
      1. Pharmaceutical & Biotechnology Companies
      2. Research Institutes
      3. Hospitals & Diagnostic Laboratories
      4. Cell Banks
    5. Global Automated Cell Culture Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea ASEAN (Association of South East Asian Countries)
        6. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Tecan Trading Ag
      2. Siemens
      3. Hitachi, Ltd
      4. Thermo Fisher Scientific Inc.
      5. Sartorius Ag
      6. Hamilton Company
      7. Beckman Coulter, Inc.
      8. F. Hoffmann-La Roche Ltd
      9. Merck Kgaa
      10. Becton, Dickinson And Company
  7. Analyst Views
  8. Future Outlook of the Market